The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Hypoglycemia-associated autonomic failure in diabetes
Abstract
Hypoglycemia is the limiting factor in the glycemic management of diabetes. The concept of hypoglycemia-associated autonomic failure (HAAF) in diabetes posits that recent antecedent iatrogenic hypoglycemia causes both defective glucose counterregulation (by reducing the epinephrine response to falling glucose levels in the setting of an absent glucagon response) and hypoglycemia unawareness (by reducing the autonomic and the resulting neurogenic symptom responses) and thus a vicious cycle of recurrent hypoglycemia. Perhaps the most compelling support for HAAF is the finding that as little as 2-3 wk of scrupulous avoidance of hypoglycemia reverses hypoglycemia unawareness and improves the reduced epinephrine component of defective glucose counterregulation in most affected individuals. Insight into this pathophysiology has led to a broader view of the clinical risk factors for hypoglycemia to include indexes of compromised glucose counterregulation and provided a framework for the study of the mechanisms of iatrogenic hypoglycemia and, ultimately, its elimination from the lives of people with diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent antecedent hypoglycemic episodes do not increase these mechanisms with a higher blood-to-brain glucose transport.”
From Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications (2024) · cites this paper as [18]
In the citing paper
“Dysfunction in these processes can lead to altered brain glucose sensing, which has far-reaching consequences on neuronal activity and overall brain physiology and can contribute to hypoglycemia unawareness syndrome [ 10 , 18 ].”
From Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications (2024) · cites this paper as [18]
In the citing paper
“Consequently, a vicious cycle of recurrent hypoglycemia with the potential for serious complications can occur [ 18 , 19 ].”
From Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications (2024) · cites this paper as [18]
In the citing paper
“Hypoglycemia unawareness syndrome is commonly observed in individuals with recurrent hypoglycemic episodes disrupting the normal release of counterregulatory hormones, such as glucagon, growth hormone (GH), and epinephrine.”
From Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications (2024) · cites this paper as [18]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Research works printed but not linked: 1
- Mühlhauser I, 1997, Diabetologia, 41, 1274
Cited by
Sorted by citations
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
“Detailed discussion of ongoing studies of these (1,58) is beyond the scope of this review.”
BackgroundHypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
“It has been suggested that the cortisol response to antecedent hypoglycaemia mediates HAAF [34, 35, 36].”
BackgroundInfluentialSelf-citationCardiac Autonomic Neuropathy in Diabetes
Pop‐Busui, R. (2010) · Diabetes Care · doi:10.2337/dc09-1294 · Cited by 486
“Hypoglycemia impairs hormonal and autonomic responses to subsequent hypoglycemia (51).”
BackgroundPop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540
“Hypoglycemia can impair hormonal and autonomic responses to subsequent hypoglycemia (8), and hypoglycemia may promote a reduced threshold for malignant arrhythmias and subsequent sudden cardiac death.”
BackgroundRouth, V. H. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00761-8 · Cited by 237
Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes
Banarer, S., & Cryer, P. E. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1195 · Cited by 186
“The reduced cortisol response to hypoglycemia during sleep in diabetic subjects is relevant to the suggestion that it is the cortisol response to prior hypoglycemia that mediates reduced autonomic (including epinephrine) and symptomatic responses to subsequent hypoglycemia (25– 26), that is, that cortisol is the media…”
InfluentialThe importance of hypoglycemia in diabetic patients
Shafiee, G., Mohajeri‐Tehrani, M. R., Pajouhi, M., & Larijani, B. A. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-17 · Cited by 170
“The mechanisms of defect in glucose counter-regulation in type 2 diabetes are the same as type 1diabetes which includes both defect in hypoglycemia counter-regulation mechanism and deficiency of sense of hypoglycemia [6].”
BackgroundWright, A. D., Cull, C. A., Macleod, K. M., & Holman, R. R. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.08.010 · Cited by 153
“Information about hypoglycemia in diabetes is largely confined to Type 1 diabetes (Cryer, 2001) and insulin requiring Type 2 diabetes, where fear of hypoglycemia is often cited as a factor-limiting attempts to intensify therapy (Cryer, 2002).”
BackgroundHan, S. M., NamKoong, C., Jang, P., Park, I.-S., Hong, S. W., Katakami, H., Chun, S., Kim, S., Park, J.-Y., Lee, K.-U., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1913-1 · Cited by 152
“Therefore, it will be interesting to study if repeated hypoglycaemia can cause a reduction in PVN AMPK activation and if a manoeuvre activating PVN AMPK can prevent HAAF.”
BackgroundInfluentialSandoval, D. A., Guy, D. L. A., Richardson, M. A., Ertl, A. C., & Davis, S. N. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1798 · Cited by 135
“This has been termed hypoglycemia-associated autonomic failure (8,9) and is proposed to create a vicious cycle of hypoglycemia for the type 1 diabetic patient.”
BackgroundFreeman, R. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00006-0 · Cited by 137
Exercise and Type 1 Diabetes (T1DM)
Galassetti, P. R., & Riddell, M. C. (2013) · Comprehensive physiology · doi:10.1002/cphy.c110040 · Cited by 143
“23”
What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Pop‐Busui, R. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9367-6 · Cited by 102
“hypoglycemia [24] and hypoglycemia unawareness may promote a reduced threshold for malignant arrhythmias and subsequent sudden cardiac death.”
BackgroundWon, S. J., Yoo, B. H., Kauppinen, T. M., Choi, B. Y., Kim, J. H., Jang, B. G., Lee, M., Sohn, M., Liu, J., Swanson, R. A., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-182 · Cited by 103
Metabolic Pathways That Mediate Inhibition of Hypothalamic Neurons by Glucose
Yang, X.-J., Kow, L., Pfaff, D. W., & Mobbs, C. V. (2004) · Diabetes · doi:10.2337/diabetes.53.1.67 · Cited by 95
“Failure in the counterregulatory responses to hypoglycemia, secondary to previous hypoglycemic episodes, constitutes a major complication in type 1 diabetes (1).”
BackgroundExercise: Applications to Childhood ADHD
Wigal, S. B., Emmerson, N., Gehricke, J.-G., & Galassetti, P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712454192 · Cited by 93
“Even these patients, however, may experience transient reductions in catecholamine responses after specific blunting stimuli, of which the best described is hypoglycemia (Cryer, 2001).”
BackgroundConcomitant Diabetes Mellitus and Heart Failure
Dei, A., Fonarow, G. C., Gheorghiade, M., & Butler, J. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.09.002 · Cited by 92
Song, Z., & Routh, V. H. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00148.2006 · Cited by 78
“Thus brain glucose levels are allowed to fall to dangerous or even lethal levels before the CRR is initiated (1, 5).”
BackgroundJansà, M., Quirós, C., Giménez, M., Vidal, M., Galindo, M., & Conget, I. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2013.11.036 · Cited by 79
Jaiswal, M., McKeon, K., Comment, N., Henderson, J., Swanson, S., Plunkett, C. D., Nelson, P. W., & Pop‐Busui, R. (2014) · Diabetes Care · doi:10.2337/dc14-0445 · Cited by 70
“, epinephrine, glucagon, and adrenocorticotropic hormone) and blunts autonomic nervous system responses to subsequent hypoglycemia (21).”
BackgroundMcGregor, V. P., Banarer, S., & Cryer, P. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00447.2001 · Cited by 66
Han, D. J., & Sutherland, D. E. R. (2010) · Gut and Liver · doi:10.5009/gnl.2010.4.4.450 · Cited by 61
“Patients with hypoglycemic unawareness with frequent reactions to exogenous insulin lead a dangerous existence.(46) Patients with progressive secondary complications of diabetes are also destined for blindness, amputations, and kidney failure that exceeds the usual side effects of immunosuppression.”
Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
de Galan, B. E., Schouwenberg, B. J. J. W., Tack, C. J., & Smits, P. (2006) · PubMed · Cited by 61
Ventromedial hypothalamus glucose‐inhibited neurones: A role in glucose and energy homeostasis?
Hirschberg, P. R., Sarkar, P., Teegala, S. B., & Routh, V. H. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12773 · Cited by 63
Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro
Kleman, A. M., Yuan, J., Aja, S. M., Ronnett, G. V., & Landree, L. E. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.028 · Cited by 58
“…in pathways that regulate energy metabolism are incurred from exposure to dysregulated metabolic environments such as during diabetes, obesity or hypoglycemia (Sango, et al., 1991; Sango, et al., 1994; Cryer, 2001; Chen, et al., 2005; Song, et al., 2006; Martin, et al., 2006; Somoza, et al., 2007).”
BackgroundPrevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes
Rossetti, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2008) · Diabetes Care · doi:10.2337/dc08-s227 · Cited by 55
Defective Counterregulation and Hypoglycemia Unawareness in Diabetes
Reno, C. M., Litvin, M., Clark, A. L., & Fisher, S. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.005 · Cited by 56
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
Awoniyi, O., Rehman, R., & Dagogo-Jack, S. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0411-y · Cited by 55
Raju, B., McGregor, V. P., & Cryer, P. E. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2083 · Cited by 45
“The clinical impact of HAAF, including the finding that as little as 2–3 weeks of scrupulous avoidance of hypoglycemia reverses hypoglycemia unawareness and improves the reduced epinephrine component of defective glucose counterregulation in most affected patients is well documented (1,4).”
BackgroundSejling, A., Kjær, T. W., Pedersen‐Bjergaard, U., Diemar, S. S., Frandsen, C. S., Hilsted, L., Faber, J. O., Holst, J. J., Tarnow, L., Nielsen, M. N., et al. (2014) · Diabetes · doi:10.2337/db14-1359 · Cited by 46
Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications
Hölzen, L., Schultes, B., Meyhöfer, S. M., & Meyhöfer, S. (2024) · Biomedicines · doi:10.3390/biomedicines12020391 · Cited by 44
“An thus hypoglycemia incretin-driven hyperinsulinemic response to undigested carbohydrates can result in a hypoglycemic episode [12,13]. awareness [18].”
BackgroundTkacs, N. C., Pan, Y., Raghupathi, R., Dunn-Meynell, A. A., & Levin, B. E. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600152 · Cited by 43
“These sequelae of recurrent hypoglycemia are termed ‘hypoglycemia unawareness’ and ‘hypoglycemiaassociated autonomic failure’ (HAAF), respectively (Gerich et al, 1991; Cryer, 2001).”
BackgroundTelemedicine for diabetes care: An Indian perspective - feasibility and efficacy
Kesavadev, J., Saboo, B., Shankar, A., Krishnan, G., & Jothydev, S. (2015) · Indian journal of endocrinology and metabolism · doi:10.4103/2230-8210.167560 · Cited by 33
Patel, P., Nankova, B. B., & LaGamma, E. F. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.08.005 · Cited by 40
Hypoglycemia-Associated Autonomic Failure Is Prevented by Opioid Receptor Blockade
Leu, J. P., Cui, M., Shamoon, H., & Gabriely, I. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0882 · Cited by 39
“compromised hypoglycemia awareness (5).”
Edelman, S. V., & Blose, J. S. (2014) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721714529608 · Cited by 37
Eisenbarth, G. S., & Buse, J. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00032-8 · Cited by 39
Jackson, L., Williams, F. L. R., Burchell, A., Coughtrie, M. W. H., & Hume, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0550 · Cited by 36
Abdelmalak, B., & Lansang, M. C. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2012.09.006 · Cited by 37
“For instance, it is likely that diabetic patients with lower blood glucose have an increased risk of hypoglycemia during the ensuing year [36,37].”
BackgroundLei, H., & Rolf Gruetter, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04115.x · Cited by 38
Parab, S., Nankova, B. B., & Gamma, E. F. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.013 · Cited by 36
Fagher, K., & Löndahl, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2860-x · Cited by 37
“Autonomic neuropathy, which might not only lead to decreased adrenergic awareness of hypoglycaemia but also to increased risk of cardiac arrhythmia, may have been more frequently present in those patients with prolonged QTc time[45].”
BackgroundNaloxone, but Not Valsartan, Preserves Responses to Hypoglycemia After Antecedent Hypoglycemia
Poplawski, M. M., Mastaitis, J. W., & Mobbs, C. V. (2010) · Diabetes · doi:10.2337/db10-0326 · Cited by 34
“Diabetes 60:39–46, 2011 Hypoglycemia-associated autonomic failure (HAAF) is thought to constitute one of the main obstacles to optimum treatment of type 1 diabetes (1).”
BackgroundUtility of continuous glucose monitoring following gastrectomy
Kubota, T., Shoda, K., Ushigome, E., Kosuga, T., Konishi, H., Shiozaki, A., Kudo, M., Arita, T., Murayama, Y., Morimura, R., et al. (2020) · Gastric Cancer · doi:10.1007/s10120-019-01036-5 · Cited by 37
“This results in a weakening of the autonomic response, termed ‘hypoglycemia-associated autonomic failure’, which further contributes to the development of hypoglycemia unawareness [17, 18].”
BackgroundMundinger, T. O., Mei, Q., Figlewicz, D. P., Lernmark, Å., & Taborsky, G. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00136.2003 · Cited by 36
“Third, the brain’s sensitivity to hypoglycemia, and thus the magnitude of sympathetic outflow from the brain, can be impaired by repetitive iatrogenic hypoglycemia, a phenomenon termed hypoglycemia-associated autonomic failure (8, 9, 23).”
BackgroundAlmby, K. E., Lundqvist, M., Abrahamsson, N., Kvernby, S., Fahlström, M., Pereira, M. J., Gingnell, M., Karlsson, F. A., Fanni, G., Sundbom, M., et al. (2021) · Diabetes · doi:10.2337/db20-1172 · Cited by 36
“attenuation of symptoms and some counterregulatory hormonal responses during hypoglycemia compared with patients with normal hypoglycemic awareness (6).”
BackgroundNeuroendocrine abnormalities in fibromyalgia
Adler, G. K., Manfredsdottir, V. F., & Creskoff, K. W. (2002) · Current Pain and Headache Reports · doi:10.1007/s11916-002-0050-5 · Cited by 51
From Bedside to Bench and Back Again: Research Issues in Animal Models of Human Disease
Tkacs, N. C., & Thompson, H. J. (2006) · Biological Research For Nursing · doi:10.1177/1099800406289717 · Cited by 37
“Recurrent hypoglycemia is associated with progressive blunting of autonomic responses to hypoglycemia, particularly manifested as a deficient epinephrine secretory response to hypoglycemia, giving rise to the phenomenon of HAAF (Cryer, 2001).”
BackgroundResultPrevention of hypoglycemia-induced neuronal death by minocycline
Won, S. J., Kim, J. H., Yoo, B. H., Sohn, M., Kauppinen, T. M., Park, M.-S., Kwon, H., Liu, J., & Suh, S. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-225 · Cited by 32
“; licensee BioMed Central Lt Commons Attribution License (http://creativec reproduction in any medium, provided the or and coma, and resulting in sudden death [7].”
BackgroundHypoglycemia-Induced Changes in the Electroencephalogram
Blaabjerg, L., & Juhl, C. B. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816659744 · Cited by 31
Jansà, M., Quirós, C., Giménez, M., Vidal, M., Galindo, M., & Conget, I. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.12.012 · Cited by 30
Devices for continuous monitoring of glucose: update in technology
Gómez, A. M., Carrillo, D. C. H., & Múñoz, Ó. (2017) · Medical Devices Evidence and Research · doi:10.2147/mder.s110121 · Cited by 30
“…cortisol, fail as beta cell function is lost, and this phenomenon has been associated with increased episodes of unawareness hypoglycemia (UH) 29,30 ; this phenomenon usually appears between 5 and 10 years after diagnosis and increases in 25 times the risk of severe hypoglycemia, and of these…”
Paranjape, S., Vavaiya, K. V., Kale, A. Y., & Briski, K. P. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.02.002 · Cited by 29
Shukla, V., Fuchs, P., Liu, A., Cohan, C. H., Dong, C., Wright, C. B., Pérez‐Pinzón, M. A., & Dave, K. R. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0622-2 · Cited by 28
“sequently increasing the risk of hypoglycemic brain injury [19, 25, 31, 32, 62].”
BackgroundAltered glycemia and brain—update and potential relevance to the aging brain
McCall, A. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.009 · Cited by 28
Metabolic Sensors Mediate Hypoglycemic Detection at the Portal Vein
Matveyenko, A. V., & Donovan, C. M. (2006) · Diabetes · doi:10.2337/db05-1665 · Cited by 27
“Because the defect in the sympathoadrenal response for type 1 diabetic patients is specific to hypoglycemia (6) and is often associated with hypoglycemic unawareness (1), impaired glucose sensing has been implicated as a cause.”
BackgroundAutonomic disturbances in diabetes: Assessment and anaesthetic implications
Moningi, S., Nikhar, S. A., & Ramachandran, G. (2018) · Indian Journal of Anaesthesia · doi:10.4103/ija.ija_224_18 · Cited by 26
“Most of them are asymptomatic due to AN.”
BackgroundInfluentialInactivation of the DMH selectively inhibits the ACTH and corticosterone responses to hypoglycemia
Evans, S. B., Wilkinson, C. W., Gronbeck, P., Bennett, J. L., Zavosh, A., Taborsky, G. J., & Figlewicz, D. P. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00328.2003 · Cited by 26
Current perspectives on neonatal hypoglycemia, its management, and cerebral injury risk
Hussain, K., Chandran, S., Rajadurai, V. S., & Alim, A. (2015) · Research and Reports in Neonatology · doi:10.2147/rrn.s55353 · Cited by 25
“Moreover, recurrent episodes of insulininduced hypoglycemia have been shown to blunt or completely prevent the secretion of counter-regulatory hormones, termed as “hypoglycaemia-associated autonomic failure”.(89,90)”
A Potential Important Role of Skeletal Muscle in Human Counterregulation of Hypoglycemia
Meyer, C., Saar, P., Soydan, N., Eckhard, M., Bretzel, R. G., Gerich, J. E., & Linn, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0225 · Cited by 24
Choi, B. Y., Kim, J. H., Kim, H. J., Yoo, J. H., Song, H. K., Sohn, M., Won, S. J., & Suh, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081523 · Cited by 23
Matveyenko, A. V., Bohland, M., Saberi, M., & Donovan, C. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2007 · Cited by 22
“Inappropriately low epinephrine and glucagon responses to hypoglycemia have been identified as the critical pathophysiological events in T1DM, because in the absence of glucagon secretion, epinephrine constitutes a primary defense against hypoglycemia (6, 8).”
BackgroundHypoglycaemia and its management in primary care setting
Ibrahim, M., Baker, J., Cahn, A., Eckel, R. H., El Sayed, N. A., Fischl, A. H., Gaede, P., Leslie, R. D., Pieralice, S., Tuccinardi, D., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3332 · Cited by 21
“arising a vicious cycle where hypoglycaemic events lead to more episodes of hypoglycaemia, which describes the concept of hypoglycaemia-associated autonomic failure (HAAF).(20) This mechanism causes a higher recurrence of severe iatrogenic hypoglycaemia.”
BackgroundNankova, B. B., Chua, J., Mishra, R., Kobasiuk, C. D., & Gamma, E. F. L. (2003) · Pediatric Research · doi:10.1203/00006450-200301000-00019 · Cited by 22
The Role of Glucosensing Neurons in the Detection of Hypoglycemia
Routh, V. H., Song, Z., & Liu, X. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774198133 · Cited by 21
Routh, V. H., Donovan, C. M., & Ritter, S. (2012) · Translational endocrinology & metabolism · doi:10.1210/team.9781936704200.ch2 · Cited by 19
Zhou, D., Qian, J., Liu, C., Chang, H. H., & Sun, R. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-007-0653-2 · Cited by 19
“The sequel of recurrent hypoglycemia is termed “hypoglycemia-associated autonomic failure” (HAAF) [4].”
Mussa, B. M., Taneera, J., Mohammed, A. K., Srivastava, A., Mukhopadhyay, D., & Sulaiman, N. D. (2019) · The Journal of Physiological Sciences · doi:10.1007/s12576-019-00718-0 · Cited by 17
Paranjape, S., Vavaiya, K. V., Kale, A. Y., & Briski, K. P. (2007) · Neuropeptides · doi:10.1016/j.npep.2006.11.001 · Cited by 17
“by diminished hypoglycemic awareness and impaired glucose counterregulation (Cryer, 2001).”
BackgroundRecognition and Management of Diabetic Neuropathy
Unger, J., & Cole, B. E. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.07.003 · Cited by 17
Direct effects of recurrent hypoglycaemia on adrenal catecholamine release
Orban, B., Routh, V. H., Levin, B. E., & Berlin, J. R. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114549755 · Cited by 16
Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference
Otlivanchik, O., Sanders, N. M., Dunn-Meynell, A. A., & Levin, B. E. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00066.2015 · Cited by 16
“HYPOGLYCEMIA UNAWARENESS AND concomitant failure to activate behavioral defenses against hypoglycemia (such as feeding) contribute to the problem of hypoglycemia-associated autonomic failure and the vicious cycle of insulin-induced hypoglycemia (IIH) in Type 1 diabetes mellitus and advanced Type 2 diabetes mellitus pa…”
BackgroundMcNay, E. C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00175 · Cited by 17
Insulin actions on hypothalamic glucose‐sensing neurones
Garcia, S. M., Hirschberg, P. R., Sarkar, P., Siegel, D. M., Teegala, S. B., Vail, G. M., & Routh, V. H. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12937 · Cited by 16
LaGamma, E. F., Kirtok, N., Chan, O. T. M., & Nankova, B. B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2014 · Cited by 15
“Despite the well-established role of hypoglycemia per se in the development of HAAF, the mechanism(s) underlying the key feature of the pathogenesis of HAAF in diabetes, the attenuated sympathoadrenal epinephrine response to falling plasma glucose levels in a background of imperfect insulin replacement and impaired gl…”
BackgroundHypoglycaemic bradycardia and circulatory collapse in a dog and a cat
Little, C. J. L. (2005) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.2005.tb00344.x · Cited by 14
Glycemia-Induced miRNA Changes: A Review
Al-Mahayni, S., Ali, M. K., Khan, M. A., Jamsheer, F., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087488 · Cited by 13
“CRR, occurs due to metabolic changes that lead to increased responsiveness to inhibitory signals generated by recurrent hypoglycemia [11,12,18,57].”
BackgroundFarhat, R., Su, G., Sejling, A.-S., Knight, N., Fisher, S. J., & Chan, O. (2019) · Diabetologia · doi:10.1007/s00125-018-4802-0 · Cited by 12
Naik, S., Belfort‐DeAguiar, R., Sejling, A., Szepietowska, B., & Sherwin, R. S. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12855 · Cited by 11
“However, intensive insulin regimens increase the risk of recurrent hypoglycaemia, which commonly induces a diminished ability to recognize hypoglycaemia (hypoglycaemia unawareness) and an impairment in the patient’s hormonal counter-regulatory response, a phenomenon known as hypoglycaemia-associated autonomic failure…”
BackgroundVieira, I. H., Barros, L. M., Baptista, C. F., Melo, M., Rodrigues, D. M., & Paiva, I. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102525 · Cited by 11
Böber, E., Büyükgebiz, A., Verrotti, A., & Chiarelli, F. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.9.831 · Cited by 10
Patel, V., Sarkar, P., Siegel, D. M., Teegala, S. B., Hirschberg, P. R., Wajid, H., Itani, O., & Routh, V. H. (2022) · Diabetes · doi:10.2337/db22-0639 · Cited by 10
Hypothalamic-Pituitary-Adrenal Axis Function in Fibromyalgia and Chronic Fatigue Syndrome
Adler, G. K., Manfredsdottir, V. F., & Rackow, R. M. (2002) · The Endocrinologist · doi:10.1097/00019616-200211000-00008 · Cited by 8
Jafari, B., & Britton, M. E. (2015) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1163 · Cited by 11
Sex Differences and Role of Estradiol in Hypoglycemia-Associated Counter-Regulation
Briski, K. P., Alhamami, H. N., Alshamrani, A. A., Mandal, S. K., Shakya, M., & Ibrahim, M. H. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_17 · Cited by 10
Sharifi, Y., Ebrahimpur, M., & Tamehrizadeh, S. S. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03498-1 · Cited by 12
“A prior study showed that diabetic patients with reduced beta-adrenergic sensitivity may be unaware of hypoglycemia, and the best suggestion for these patients is to strictly avoid hypoglycemia [35, 36].”
BackgroundPancreas and Islet Transplant Population
Sutherland, D. E. R. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_6 · Cited by 9
Bengtsen, M. B., & Møller, N. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac123 · Cited by 9
“Though the term impaired awareness of hypoglycemia (IAH) [14] is related to HAAF, studies merely investigating IAH were excluded, as we opted for the HAAF definition coined by Philip Cryer predicating the coexistence of defective hormonal counterregulatory response and hypoglycemia unawareness [15].”
Jiang, H., Niu, J.-J., Zhang, W., Huang, W., Zhou, M.-Y., Sha, W., Li, J., Li, F., Zhu, T., Xia, X., et al. (2014) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(14)60008-x · Cited by 8
Cade, W. T., Khoury, N., Nelson, S., Shackleford, A. M., Semenkovich, K. A., Krauss, M. J., & Arbeláez, A. M. (2016) · Physiological Reports · doi:10.14814/phy2.12848 · Cited by 8
“…of hypoglycemia, such as the one seen during exercise in our experiment, can reduce the sympathoadrenal and symptomatic responses to subsequent hypoglycemia (Davis et al. 2000; Cryer 2012), causing defective glucose counterregulation and hypoglycemia unawareness (Gold et al. 1994; Cryer 2001).”
BackgroundJacobson, L., & Pacák, K. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.013 · Cited by 7
“Inadequate glucagon secretion renders the sympathetic nervous system response to hypoglycemia more important because after glucagon, epinephrine has the most rapid action to restore blood sugar [1].”
BackgroundBriski, K. P., Kale, A. Y., & Vavaiya, K. V. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1787-4 · Cited by 7
Schwab, K., Menche, U., Schmeisl, G., & Lohse, M. J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080064 · Cited by 7
Martine‐Edith, G., Zaremba, N., Divilly, P., Søholm, U., Broadley, M. M., Baumann, P. M., MAHMOUDI, Z., Gomes, M., Ali, N., Abbink, E. J., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0596 · Cited by 6
“2,3 Hypoglycemia symptoms are often grouped into autonomic symptoms such as heart palpitations, shaking, and sweating, resulting from the activation of the autonomic nervous sys-tem 4,5 and neuroglycopenic symptoms, including headache, confusion, and dizziness, typically considered to manifest as a…”
McCarthy, O. M., Pitt, J. P., Churm, R., Dunseath, G. J., Jones, C., Bally, L., Nakas, C. T., Deere, R., Eckstein, M. L., Bain, S. C., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001577 · Cited by 8
Insulin enhances contextual fear memory independently of its effect in increasing plasma adrenaline
Oliveira, A., Seixas, R., Pereira, F., Azevedo, M., Martinho, R., Serrão, P., & Moreira-Rodrigues, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121881 · Cited by 6
Reno, C. M., Ding, Y., & Sherwin, R. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2015 · Cited by 6
Breton, M. D., Clarke, W. L., Farhy, L. S., & Kovatchev, B. P. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100304 · Cited by 6
Farhat, R., Vliet, E. D. S. V., Su, G., Neely, L., Benally, T., & Chan, O. T. M. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.226 · Cited by 5
Metadata
- Authors
- Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Cryer, Philip E.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2001-12-01
- Volume
- 281
- Issue
- 6
- Pages
- E1115-E1121
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1931223844
- Cited by
- 152
- References
- 76
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 10 · 2014: 10 · 2013: 9 · 2012: 8
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60dk020579-35)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027085, P60-DK20579, R37-DK27085, T32 DK07120, T32DK007120)
- National Center for Research Resources (M01-RR00036, M01RR000036)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- hypoglycemia-associated autonomic failure, iatrogenic hypoglycemia, diabetes mellitus, glucose counterregulation, hypoglycemia unawareness, epinephrine response, glucagon response, neurogenic symptoms, glycemic control, hypoglycemia risk factors
- MeSH terms
- Animals, Autonomic Nervous System Diseases, Diabetes Mellitus, Glucose, Humans, Hypoglycemia, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review